Momelotinib is a highly potent inhibitor of FLT3-mutant AML

Autor: Azhar, Mohammad, Kincaid, Zachary, Kesarwani, Meenu, Ahmed, Arhama, Wunderlich, Mark, Latif, Tahir, Starczynowski, Daniel, Azam, Mohammad *
Zdroj: In Blood Advances 22 February 2022 6(4):1186-1192
Databáze: ScienceDirect